Suppr超能文献

焦虑障碍患者首次药物治疗(未治疗疾病持续时间)潜伏期的差异:惊恐障碍、广泛性焦虑障碍和强迫症患者的研究。

Differences in latency to first pharmacological treatment (duration of untreated illness) in anxiety disorders: a study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder.

机构信息

Department of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Early Interv Psychiatry. 2013 Nov;7(4):374-80. doi: 10.1111/eip.12016. Epub 2013 Jan 24.

Abstract

AIM

The latency to first pharmacological treatment (duration of untreated illness or 'DUI') is supposed to play a major role in terms of outcome in psychotic conditions. Interest in the field of affective disorders and, in particular, of duration of untreated anxiety, has been recently registered as well. However, a preliminary epidemiologic investigation of the phenomenon is necessary. The present study was aimed to investigate and compare age at onset, age at first pharmacological treatment and DUI in a sample of patients affected by different anxiety disorders. DUI was defined as the interval between the onset of the specific anxiety disorder and the administration of the first adequate pharmacological treatment in compliant subjects.

METHODS

Study sample included 350 patients, of both sexes, with a DSM-IV-TR diagnosis of panic disorder (n = 138), generalized anxiety disorder (n = 127) and obsessive-compulsive disorder (n = 85).

RESULTS

Panic disorder was associated with the shortest DUI (39.5 months), whereas obsessive-compulsive disorder was associated with the longest latency to treatment (94.5 months) (F = 13.333; P < 0.0001). Patients with generalized anxiety disorder showed a mean DUI of 81.6 months.

CONCLUSION

Present results indicate that patients with different anxiety disorders may wait for years (from 3 up to 8) before receiving a first adequate pharmacological treatment. Differences in terms of age at onset, age at the first pharmacological treatment and, ultimately, in DUI in specific anxiety disorders may depend on multiple clinical and environmental factors. Latency to non-pharmacological interventions (e.g. psychoeducation and different forms of psychotherapy) needs to be addressed and correlated with DUI in future studies.

摘要

目的

首次药物治疗的潜伏期(未治疗疾病的持续时间或“DUI”)在精神病患者的预后中起着重要作用。情感障碍领域,特别是未治疗焦虑症的持续时间,最近也引起了人们的关注。然而,有必要对这一现象进行初步的流行病学调查。本研究旨在调查和比较不同焦虑障碍患者的发病年龄、首次药物治疗年龄和 DUI。DUI 定义为特定焦虑障碍发作与依从性受试者首次接受适当药物治疗之间的间隔。

方法

研究样本包括 350 名符合 DSM-IV-TR 诊断标准的男性和女性患者,分别患有惊恐障碍(n=138)、广泛性焦虑障碍(n=127)和强迫症(n=85)。

结果

惊恐障碍患者的 DUI 最短(39.5 个月),而强迫症患者的治疗潜伏期最长(94.5 个月)(F=13.333;P<0.0001)。广泛性焦虑障碍患者的 DUI 平均为 81.6 个月。

结论

目前的结果表明,不同焦虑障碍患者可能需要数年(3 至 8 年)才能接受首次适当的药物治疗。特定焦虑障碍在发病年龄、首次药物治疗年龄以及最终 DUI 方面的差异可能取决于多种临床和环境因素。未来的研究需要探讨并关联非药物干预(如心理教育和不同形式的心理治疗)的潜伏期和 DUI。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验